Relationship Between Skin Shame, Psychological Distress and Quality of Life in Patients with Psoriasis: a Pilot Study.
Psoriasis Area and Severity Index
SHAME
disease burden
quality of life
skin shame
psoriasis
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
02 Jul 2020
02 Jul 2020
Historique:
pubmed:
20
6
2020
medline:
24
6
2021
entrez:
20
6
2020
Statut:
epublish
Résumé
Shame has been registered as a part of psychosocial distress in patients with psoriasis. This study investigated 44 patients with psoriasis and 88 age- and sex-matched individuals without skin disease. Skin shame, multifarious expressions of shame, psychological symptoms, overall health, dermatological quality of life, disease burden and disease severity were measured. Higher levels of skin shame correlated with a greater disease burden (r=0.63; p < 0.01), higher Dermatology Life Quality Index (r=0.33; p < 0.05), and lower mental quality of life (r=-0.30; p <´ 0.05). Patients had a higher level of skin shame (F=74.03; eta2= 0.36; p < 0.01) and less physical quality of life on the SF-36 (F=5.14; eta2= 0.04; p < 0.05) than non-dermatological controls. General shame was not related to disease burden or quality of life. While self-rated skin shame appears to be related to quality of life in patients with psoriasis, no association was registered between expert-rated Psoriasis Area and Severity Index and quality of life.
Identifiants
pubmed: 32556357
doi: 10.2340/00015555-3563
pmc: PMC9199924
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv00205Références
Br J Clin Psychol. 2002 Jun;41(Pt 2):157-74
pubmed: 12034003
J Invest Dermatol. 2014 Jun;134(6):1527-1534
pubmed: 24166134
Clin Exp Dermatol. 2014 Jul;39(5):600-3
pubmed: 24758704
Postepy Dermatol Alergol. 2013 Aug;30(4):233-6
pubmed: 24278080
Am J Clin Dermatol. 2003;4(12):833-42
pubmed: 14640776
Cutis. 1998 Jun;61(6):339-42
pubmed: 9640555
Physiol Behav. 2000 Sep 15;70(5):567-71
pubmed: 11111012
J Invest Dermatol. 2014 Jun;134(6):1542-1551
pubmed: 24284419
Fortschr Neurol Psychiatr. 2011 Sep;79(9):517-23
pubmed: 21870312
Acta Derm Venereol. 2016 Aug 23;96(217):78-82
pubmed: 27282125
J Rheumatol. 2015 May;42(5):835-40
pubmed: 25834201
Acta Derm Venereol. 2010 May;90(3):251-6
pubmed: 20526541
J Invest Dermatol. 2004 Mar;122(3):602-7
pubmed: 15086541
Br J Dermatol. 2020 Jul;183(1):169-171
pubmed: 31997342
Am J Clin Dermatol. 2005;6(6):383-92
pubmed: 16343026
J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):388-94
pubmed: 9091469
Br J Dermatol. 2018 Aug;179(2):237-238
pubmed: 30141548
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
Med Care. 1993 Mar;31(3):247-63
pubmed: 8450681
Br J Dermatol. 2001 May;144(5):967-72
pubmed: 11359382
Dermatol Online J. 2014 Aug 17;20(8):
pubmed: 25148272
J Invest Dermatol. 2015 Apr;135(4):984-991
pubmed: 25521458
Br J Dermatol. 2016 Nov;175(5):930-936
pubmed: 27169607
J Psychosom Res. 1997 May;42(5):467-75
pubmed: 9194019
Br J Dermatol. 2017 Mar;176(3):687-694
pubmed: 27436615
J Invest Dermatol. 2017 Apr;137(4):828-835
pubmed: 28237512
Annu Rev Psychol. 2007;58:345-72
pubmed: 16953797
Expert Rev Clin Immunol. 2018 May;14(5):405-417
pubmed: 29681202
Acta Derm Venereol. 2012 May;92(3):299-303
pubmed: 22678565
Subst Use Misuse. 2020;55(3):441-451
pubmed: 31729286
Hautarzt. 2020 Feb;71(2):124-129
pubmed: 31712973